BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CMS QIN-QIO - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://qi.ipro.org
X-WR-CALDESC:Events for CMS QIN-QIO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241009T150000
DTEND;TZID=America/New_York:20241009T160000
DTSTAMP:20260416T040837
CREATED:20240912T125743Z
LAST-MODIFIED:20240912T125743Z
UID:38144-1728486000-1728489600@qi.ipro.org
SUMMARY:IPRO QIN-QIO Presents: A Pathway to Transforming Patient Care through a Pain and Opioid Learning Health System (LHS) Collaborative (POLLC)
DESCRIPTION:Wednesday\, October 9 from 3 to 4 pm ET\nRegistration Link: https://bit.ly/47jRmnm\nLearning Objectives\nIn this webinar\, we will: \n\nDefine the characteristics and benefits of a Learning Health System\nDescribe foundational POLLC activities to support Learning Health Systems aimed at advancing evidence driven pain and opioid management and improving patient outcomes\nProvide a Round Table on lessons learned from POLLC participants\nEnable participants to design their LHS leveraging POLLC tools and resources\n\nAudience\nThis activity is appropriate for all those interested in improving pain and opioid management and outcomes\, and/or improving Learning Health Systems for other conditions. This includes: \n\nClinicians (e.g.\, Physicians\, NPs\, PAs\, Nurses\, Pharmacists)\, Public Health Professionals\, Patients and/or Care Partners\nHealth Systems\, Hospitals\, Primary Care\, Specialty Clinics\, Nursing Homes\, and Health IT vendors\n\nSpeakers\nJerry Osheroff\, MD – Principal\, TMIT Consulting\, LLC\nDr. Jerry Osheroff is a primary care physician by training who has focused for over 30 years on developing and implementing approaches to improve healthcare delivery processes and outcomes. He is a principal of TMIT Consulting\, LLC and a care transformation subject matter expert helping VA become a learning health system and achieve the quintuple aim. He is the lead author on influential guidebooks and national roadmaps for achieving these goals and brings together diverse stakeholders to implement the recommendations (e.g.\, via initiatives such as POLLC and ACT) and accelerate improvements in care delivery and results. \nAnne Myrka\, RPh\, MAT\, CPHQ – Senior Director of Drug Safety ad Chronic Disease Management\, IPRO\nAnne Myrka earned a Bachelor of Science in Pharmacy from Albany College of Pharmacy and Health Sciences and a Master of Arts in Teaching Science from the State University at New Paltz. She is a licensed pharmacist in New York and Vermont. She has presented nationally about high-risk medication management\, care transitions\, and medication reconciliation\, and has co-authored multiple peer-reviewed journal articles on these topics. \nLynn Wilson\, MS – Senior Quality Improvement Specialist\, IPRO\nLynn Wilson has more than 30 years of experience with regulatory agencies for community mental health centers and nursing homes and is a nationally recognized QI leader in long-term care\, behavioral health and hospice and palliative care settings. Under her leadership\, behavioral health and end of-life care practice innovations generated through frontline staff quality improvement processes have been recognized as national best practices.
URL:https://qi.ipro.org/upcoming-events/ipro-qin-qio-presents-a-pathway-to-transforming-patient-care-through-a-pain-and-opioid-learning-health-system-lhs-collaborative-pollc/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240607T120000
DTEND;TZID=America/New_York:20240607T130000
DTSTAMP:20260416T040837
CREATED:20230831T193028Z
LAST-MODIFIED:20230831T194613Z
UID:36434-1717761600-1717765200@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 9
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 9: Management of Patients on MOUD: Key Takeaways and Series Wrap Up \nIn this session\, a general certificate of attendance will be provided for continuing education/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification for their discipline.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-9/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240510T120000
DTEND;TZID=America/New_York:20240510T130000
DTSTAMP:20260416T040837
CREATED:20230831T192840Z
LAST-MODIFIED:20230831T194544Z
UID:36432-1715342400-1715346000@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 8
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 8: Sustaining Recovery for Patients on MOUD Part 2  \nIn this session\, we will discuss Alternatives to Opioids (ALTO)\, peer support\, narcotics anonymous meetings\, counseling\, and use of technologies.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-8/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240412T120000
DTEND;TZID=America/New_York:20240412T130000
DTSTAMP:20260416T040837
CREATED:20230831T192628Z
LAST-MODIFIED:20230831T194522Z
UID:36430-1712923200-1712926800@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 7
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 7: Sustaining Recovery for Patients on MOUD Part 1  \nIn this session\, we will discuss Alternatives to Opioids (ALTO)\, peer support\, narcotics anonymous meetings\, counseling\, and use of technologies.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-7/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240308T120000
DTEND;TZID=America/New_York:20240308T130000
DTSTAMP:20260416T040837
CREATED:20230831T192231Z
LAST-MODIFIED:20230831T194434Z
UID:36427-1709899200-1709902800@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 6
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 1: Management of Patients on MOUD During the Nursing Home Stay Part 2  \nIn this session\, we will discuss admissions assessment & treatment\, addressing stigma\, and naloxone training.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-6/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240209T120000
DTEND;TZID=America/New_York:20240209T130000
DTSTAMP:20260416T040837
CREATED:20230831T191952Z
LAST-MODIFIED:20230831T194339Z
UID:36425-1707480000-1707483600@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 5
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 5: Management of Patients on MOUD During the Nursing Home Stay Part 1 \nIn this session\, we will discuss admissions assessment & treatment\, addressing stigma\, and naloxone training.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-5/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240112T120000
DTEND;TZID=America/New_York:20240112T130000
DTSTAMP:20260416T040837
CREATED:20230831T190929Z
LAST-MODIFIED:20230831T194230Z
UID:36417-1705060800-1705064400@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 4
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 4: Seamlessly Transitioning Patients on MOUD to Nursing Homes Part 2 \nIn this session\, we will discuss discharge planning\, medication reconciliation\, and readmission prevention.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-4/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231117T120000
DTEND;TZID=America/New_York:20231117T130000
DTSTAMP:20260416T040837
CREATED:20230831T190611Z
LAST-MODIFIED:20230831T194148Z
UID:36415-1700222400-1700226000@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 3
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 3: Seamlessly Transitioning Patients on MOUD to Nursing Homes Part 1 \nIn this session\, we will discuss discharge planning\, medication reconciliation\, and readmission prevention.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-3/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231116T190000
DTEND;TZID=America/New_York:20231116T200000
DTSTAMP:20260416T040837
CREATED:20231025T144213Z
LAST-MODIFIED:20231025T144213Z
UID:36760-1700161200-1700164800@qi.ipro.org
SUMMARY:Recognizing and Responding to an Opioid-Involved Breathing Emergency
DESCRIPTION:Learning Objectives \nAt the completion of this activity learners will be able to: \n\nDescribe how to effectively recognize and respond to an opioid-involved breathing emergency\, including considerations with xylazine and illicitly manufactured fentanyl.\nCounsel patients and caregivers on how to use unregulated substances more safely and where to find recovery resources.\nDispel myths and provide facts related to medications for opioid use disorder\, passive fentanyl exposure\, various naloxone formulations\, and liability concerns.\n\nSpeaker \nAnita Jacobson\, PharmD \nClinical Professor; Program Director\, Community First Responder Program (CFRP) \nUniversity of Rhode Island College of Pharmacy                 \nDr. Anita Jacobson is a Clinical Professor at the University of Rhode Island College of Pharmacy and has worked as a pharmacist in a variety of patient care settings for 25 years. She is the Program Director of the Community First Responder Program (CFRP) which focuses on harm reduction\, overdose education and naloxone outreach to at-risk populations. CFRP is also the hub for the Northeast Regional Rural Opioid Technical Assistance Center \nThe University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 1 contact hour (0.1 CEUs) for the educational activity. No partial credit is available. UNIVERSAL ACTIVITY NUMBER (UAN): 0060-0000-23-040-L01-P. Expiration Date 05/04/2026. \nSocial Work This activity has been approved by the National Association of Social Workers Rhode Island Chapter for 1.0 credit hour. NASW Authorization # RI-9028. Expiration Date: 04/30/2025. \nLicensed Mental Health Counselors This activity has been reviewed and approved by the Rhode Island Mental Health Counselors Association for up to 1.0 contact hour (1.0 CEUs). Expiration Date: 07/25/2024. \nNursing This nursing continuing professional development activity was approved by the Northeast Multistate Division Education Unit\, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation for up to 1.0 contact hour. NEMSD Approval # 557-790-081622. Expiration Date: 08/16/2024. \n PROGRAM EVALUATION \nAll participants will have the opportunity to evaluate the educational sessions\, speakers and identify educational needs. \n REQUIREMENTS FOR CE CREDIT \nA program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date (1/15/2024) in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit. \n FACULTY DISCLOSURE: Relevant conflicts of interest will be disclosed to participants at the start of the educational activity.
URL:https://qi.ipro.org/upcoming-events/recognizing-and-responding-to-an-opioid-involved-breathing-emergency/
LOCATION:Online via WebEx
CATEGORIES:Hospital event,Nursing Home,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231013T120000
DTEND;TZID=America/New_York:20231013T130000
DTSTAMP:20260416T040837
CREATED:20230831T185829Z
LAST-MODIFIED:20230831T194048Z
UID:36411-1697198400-1697202000@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 2
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 2: Role of the Pharmacist in the Treatment of Patients with OUD \nIn this session\, we will explain medication processes and address opioid adverse drug events (ADEs) and risk assessment for opioid prescribing.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-2/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230915T120000
DTEND;TZID=America/New_York:20230915T130000
DTSTAMP:20260416T040837
CREATED:20230831T185453Z
LAST-MODIFIED:20230831T191243Z
UID:36408-1694779200-1694782800@qi.ipro.org
SUMMARY:Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 1
DESCRIPTION:More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.\nHowever\, fewer than one in five received medication to treat this condition. In addition\, the number of patients who stay in treatment after hospital discharge decrease drastically. \nThis webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies\, interventions\, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum. \nSession 1: Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD  \nIn this session\, we will describe the basics and science of addiction; screening and initiating MOUD.
URL:https://qi.ipro.org/upcoming-events/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-session-1/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230814T110000
DTEND;TZID=America/New_York:20230814T170000
DTSTAMP:20260416T040837
CREATED:20230803T191440Z
LAST-MODIFIED:20230803T202352Z
UID:36117-1692010800-1692032400@qi.ipro.org
SUMMARY:Opioid Stewardship Affinity Group
DESCRIPTION:WHAT IS AN AFFINITY GROUP?\nAffinity Groups highlight best practices\, resources\, and successful solutions to challenges. Opioid Stewardship Affinity Group attendees will: \n\nDiscuss how to initiate/expand a hospital Opioid Stewardship program.\nShare best practices\, resources\, and successful solutions to challenges.\nPose questions to subject matter experts (SMEs) who have implemented successful programs.\nEvaluate data and outcome measures.\n\nDATES\, TIMES\, TOPICS AND SMEs \nAugust 14\, 2023\n11 am – 12 pm EST (10 – 11 am CST) \nLisa Caswell\, RPh\nDirector of Pharmacy\nRedington-Fairview General Hospital \nCynthia Currier\, BS Education\, MHRT-C (Provisional)\nPatient Navigator\nSomerset Public Health (a department of Redington-Fairview General Hospital) \nObjectives:\nRedington-Fairview General Hospital\, Maine \n\nOutline opioid prescribing practices at a rural hospital.\nDescribe medication-assisted treatment options and options for addressing stigma.\nDescribe the role of the patient navigator.\nDescribe one harm reduction focus (Narcan distribution).\nRecognize the wider community involvement in addressing opiate misuse and stigma.\n\nMark Shen\, PharmD.\, BCPS\nClinical Pharmacist: Transitions of Care\nCo-Chair: Pain Management Committee\nPGY-1 Pharmacy Practice Residency Program Coordinator NYU Langone Hospital-Long Island \nObjectives:\nNYU Langone Hospital\, Long Island\, New York \n\nReview baseline surgery-related opioid prescribing patterns after coronary artery bypass graft surgery.\nDiscuss current best practices for post-surgical opioid prescribing.\nList interventions to decrease the number of opioid tablets provided on patient discharge.\nDescribe the outcomes/successes of the intervention.
URL:https://qi.ipro.org/upcoming-events/opioid-stewardship-affinity-group/
LOCATION:Online via WebEx
CATEGORIES:Free event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230628T130000
DTEND;TZID=America/New_York:20230628T140000
DTSTAMP:20260416T040837
CREATED:20230614T175508Z
LAST-MODIFIED:20230614T175508Z
UID:35777-1687957200-1687960800@qi.ipro.org
SUMMARY:Ensuring Equitable Care: Understanding the Role of Trauma and Stigma in the Lives of Residents with a History of Addiction and Chronic Pain
DESCRIPTION:IPRO and the Opioid Response Network (ORN) have developed an education series for use by nursing home staff educators. Our goal is to provide a resource to nursing homes/medical rehabilitation centers that supports your commitment to ensure all residents/patients receive equitable care. This education series will address the often missed\, yet impactful issues of addiction\, trauma\, stigma\, and chronic pain management. \nThis pre-packaged\, two-month\, 6 module education series includes: \n\n3 live webinars\, with Delores Blackwell\, PhD (before\, during and after the series) for educators to review the education materials supplied and receive support in presenting the content.\nEducational content for all staff in a series of 6 education sessions designed to last 25-30 minutes each. Included for each session:\n\n6 prerecorded modules (15 minutes)\nWritten materials to support discussion led by the educator (10-15 minutes)\n\n\n\nIt is strongly recommended that the series be conducted over 6 consecutive weeks. Note: Materials can be used at any time. \nJoin us for the first live session with Dr. Blackwell on Wednesday\, June 28\, 2023\, at 1 pm.
URL:https://qi.ipro.org/upcoming-events/ensuring-equitable-care-understanding-the-role-of-trauma-and-stigma-in-the-lives-of-residents-with-a-history-of-addiction-and-chronic-pain/
LOCATION:Online via WebEx
CATEGORIES:Free event,Nursing Home,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230525T110000
DTEND;TZID=America/New_York:20230525T120000
DTSTAMP:20260416T040837
CREATED:20230403T133702Z
LAST-MODIFIED:20230519T193309Z
UID:35311-1685012400-1685016000@qi.ipro.org
SUMMARY:PROGRAM CANCELLED: Paving the Way for Evidence-Based Care across the Continuum
DESCRIPTION:Join us as Seth Clark\, MD & Juliette Holtzman\, MSW from LifeSpan Addiction Medicine team share their approach to supporting individuals living with Opioid Use Disorder. \nUpon attending this session\, participants will be able to: \n1.       Identify key considerations to support uptake of patient-centered and evidence-based care.\n2.       Explore promising practices for delivering treatment for opioid use disorder.\n3.       Consider steps to enrich treatment efforts across your community. \n  \n 
URL:https://qi.ipro.org/upcoming-events/paving-the-way-for-evidence-based-care-across-the-continuum/
CATEGORIES:Free event,Hospital event,Nursing Home,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230518T110000
DTEND;TZID=America/New_York:20230518T120000
DTSTAMP:20260416T040837
CREATED:20230403T133325Z
LAST-MODIFIED:20230515T162534Z
UID:35307-1684407600-1684411200@qi.ipro.org
SUMMARY:Universal Precautions in Pain Management: A Person-Centered Approach to Preventing Opioid Misuse
DESCRIPTION:Join Healthcentric Advisors’ Dr. Rebekah Gardner and Marghie Guiliano as well as Jenn McCarthy\, LPC\, New England Rural Health Association\, to explore validated assessment tools\, consider the new CDC prescribing guidelines\, discuss complementary therapies\, and explore tools and resources that will help your team support your patients and community. \nUpon attending this session\, participants will be able to: \n1.       Implement evidence-based assessments of patients’ physical and behavioral needs.\n2.       Describe a holistic treatment plan.\n3.       Access tools and resources to better support patients and the community. \n \nView Slides
URL:https://qi.ipro.org/upcoming-events/universal-precautions-in-pain-management-a-person-centered-approach-to-preventing-opioid-misuse/
LOCATION:Online via Zoom
CATEGORIES:Free event,Hospital event,Nursing Home,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230427T110000
DTEND;TZID=America/New_York:20230427T120000
DTSTAMP:20260416T040837
CREATED:20230403T132745Z
LAST-MODIFIED:20230511T140516Z
UID:35301-1682593200-1682596800@qi.ipro.org
SUMMARY:Harm Reduction: Making a Difference through Implementation in Practice
DESCRIPTION:Join us to learn about promising practices from Berkshire Health\, Vermont CARES and the NH Harm Reduction program. We welcome you to share about your efforts too!   \nUpon attending this session\, participants will be able to: \n1.       Define and understand the practice and key principles of harm reduction.\n2.       Implement key strategies of harm reduction in your policies and practice.\n3.       Increase knowledge of harm reduction tools and resources to better support your patients and community. \nView Slides
URL:https://qi.ipro.org/upcoming-events/harm-reduction-making-a-difference-through-implementation-in-practice/
LOCATION:Online via Zoom
CATEGORIES:Free event,Hospital event,Nursing Home,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230213T110000
DTEND;TZID=America/New_York:20230213T120000
DTSTAMP:20260416T040837
CREATED:20221208T153844Z
LAST-MODIFIED:20221208T153844Z
UID:34581-1676286000-1676289600@qi.ipro.org
SUMMARY:The IPRO NQIIC Invites You to Join the Opioid Stewardship Affinity Group
DESCRIPTION:In the United States\, During the time period between 1999 and 2020\, more than 263\,000 people died from overdoses involving prescription opioids. As many as one in four people receiving prescription opioids in a primary care setting struggles with addiction. Between January 2019 and June 2020\, more than 90% of benzodiazepine-involved overdose deaths also involved opioids. \nParticipate with other hospital clinicians and subject matter experts in conversations focused on how to initiate or expand opioid stewardship programs. Opioid Stewardship Affinity Group meetings will highlight best practices\, resources and successful solutions to challenges. \nThe meeting format will provide participants opportunities to pose questions to subject matter experts (SMEs) who have implemented successful programs. They will discuss data evaluation and outcome measures and provide tips for sustaining a successful program. \nMEETING 2\nFebruary 13\, 2023 • 11 am–12 pm EST ( 10–11 am CST)\nTopics: Local Practices and Current Topics
URL:https://qi.ipro.org/upcoming-events/the-ipro-nqiic-invites-you-to-join-the-opioid-stewardship-affinity-group/
LOCATION:Online via WebEx
CATEGORIES:Free event,Hospital event,Opioid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221212T110000
DTEND;TZID=America/New_York:20221212T120000
DTSTAMP:20260416T040837
CREATED:20221208T153503Z
LAST-MODIFIED:20221208T153503Z
UID:34575-1670842800-1670846400@qi.ipro.org
SUMMARY:The IPRO NQICC Invites You to Join the Opioid Stewardship Affinity Group
DESCRIPTION:In the United States\, During the time period between 1999 and 2020\, more than 263\,000 people died from overdoses involving prescription opioids. As many as one in four people receiving prescription opioids in a primary care setting struggles with addiction. Between January 2019 and June 2020\, more than 90% of benzodiazepine-involved overdose deaths also involved opioids. \nParticipate with other hospital clinicians and subject matter experts in conversations focused on how to initiate or expand opioid stewardship programs. Opioid Stewardship Affinity Group meetings will highlight best practices\, resources and successful solutions to challenges. \nThe meeting format will provide participants opportunities to pose questions to subject matter experts (SMEs) who have implemented successful programs. They will discuss data evaluation and outcome measures and provide tips for sustaining a successful program. \nINAUGURAL MEETING\nDecember 12\, 2022 • 11 am–12 pm EST (10–11 am CST)\nTopics: Education\, Staffing\, EHR solutions\, Outcomes \nSUBJECT MATTER EXPERTS \n\n\nMaura L. Osborne\, PharmD\, BCPS\nClinical Manager\, Department of Pharmacy\,\nCommonwealth Health – Regional Hospital of Scranton\n746 Jefferson Ave\, Scranton\, PA 18510 \n\n\nKara Harrer\, PharmD\nDirector of Pharmacy\,\nCalvert Health Medical Center\,\n100 Hospital Road\, Prince Frederick\, MD 20678
URL:https://qi.ipro.org/upcoming-events/the-ipro-nqicc-invites-you-to-join-the-opioid-stewardship-affinity-group/
LOCATION:Online via WebEx
CATEGORIES:Free event,Hospital event,Opioid
END:VEVENT
END:VCALENDAR